Daily coverage of equity markets, sectors, and major indices.
In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.
17,913 total articles
Quoin Pharmaceuticals Ltd. filed an Investigational New Drug application with the U.S. Food and Drug Administration for QRX003 to treat Peeling Skin Syndrome, a disorder with no approved therapies. Shares rose about 5.6% in premarket trading following the announcement. The company plans a Phase 2 trial in the second half of 2026, supported by clini…
Safe Pro Group Inc. said it secured a subcontracted award tied to a U.S. Army procurement for an AI-driven threat analysis kit. The order, which includes the company’s NODE edge compute system, licensed SPOTD detection technology, Black Widow drones from Red Cat Holdings, annual software upgrades and operational field support, prompted a premarket …
Lantern Pharma Inc. (NASDAQ: LTRN) saw shares rise 3.5% in premarket trading after releasing updated survival results from its Phase 2 HARMONIC trial. Patients with EGFR Exon 21 L858R-mutant non-small cell lung cancer treated with LP-300 plus carboplatin and pemetrexed reached a median progression-free survival of 8.9 months. The company filed the …
Cisco on June 2 introduced Cloud Control, a software suite that enables organizations to build and manage AI agents to monitor and defend IT systems. The launch aims to provide machine-scale cyber defenses in response to an evolving threat landscape in which attackers may soon harness more powerful AI models. Cisco will embed OpenAI's Codex as the …
Candel Therapeutics reported peer-reviewed publication of a pivotal phase 3 trial in The Lancet Oncology showing statistically significant improvements in disease-free survival and prostate cancer-specific disease-free survival for aglatimagene besadenovec plus radiotherapy. The company’s shares fell 2.4% in premarket trading following the publicat…
The software sector swung from a sharp rally to a swift sell-off as investor optimism about AI agents collided with automated trading flows. A sector ETF erased half of a one-day gain and a wide set of leading software names fell, even after Nvidia CEO Jensen Huang argued that AI agents will increase demand for software tools. Separately, Anthropic…
Insiders and affiliated investment vehicles reported a mix of heavyweight purchases and large-scale disposals on Monday, June 1, 2026. Biotech Q32 Bio and clinical-stage Outlook Therapeutics recorded significant private and registered-direct purchases, while a coordinated block sale at Medline and large fund dispositions of Illumina shares dominate…
Futures tied to Canada’s commodity-heavy main equity gauge moved modestly higher on Tuesday, supported by gains in gold even as crude prices fell amid continued ambiguity over the status of U.S.-Iran peace negotiations. U.S. futures were mixed to lower as investors parsed a raft of technology-sector headlines and the impact of geopolitical developm…
Enveric Biosciences said it has initiated Good Laboratory Practice genotoxicity studies on its lead neuroplastogen candidate, EB-003. The tests, conducted in line with ICH S2(R1) guidance, will evaluate whether the compound interacts with DNA and could cause genetic mutations - a required safety assessment for an Investigational New Drug filing. Sh…
Morningstar's appraisal places SpaceX at $780 billion, substantially lower than the $1.75 trillion valuation the company is targeting for its upcoming IPO. The research house singled out uncertainties around SpaceX's artificial intelligence initiatives, including xAI and X, and noted technological and competitive risks for Starlink and proposed orb…
VCI Global Ltd reported that its wholly owned unit, V Gallant Limited, has entered a definitive agreement to acquire PT Fine Carbon Credit Indonesia, a carbon-asset platform linked to roughly 241,000 hectares of forestry across four project sites in Indonesia. The announcement preceded an 18.1% slide in VCI Global shares in premarket trading. The c…
Morningstar values SpaceX at $780 billion, substantially lower than the company's stated IPO target. The research firm questioned the economics and competitive position of SpaceX's AI initiatives and highlighted technological and external risks for Starlink. Despite near-term upside driven by low float and heavyweight underwriters, Morningstar caut…
Goldman Sachs' review of nearly all S&P 500 constituents finds real revenues excluding energy up 6.3% year-over-year in Q1. Companies reported limited signs of demand weakening even as the Iran war and higher oil prices pushed input costs and squeezed margins. AI spending by hyperscalers and corporate capital expenditure plans remain a key growth e…
Saudi Arabia's main stock gauge closed marginally higher on Tuesday, lifted by advances in Telecoms & IT, Cement and Financial Services. The Tadawul All Share finished up 0.05%, with notable moves among individual stocks while commodities and currency markets showed modest shifts during the session.
Cingulate Inc. (NASDAQ: CING) saw its stock fall roughly 20% following disclosure that the U.S. Food and Drug Administration issued a Complete Response Letter for the company's New Drug Application for CTx-1301, an attention deficit/hyperactivity disorder treatment. The FDA's response focused on Chemistry, Manufacturing and Controls (CMC) informati…
Stellantis plans to build 2 million cars per year on its STLA One architecture by 2035, aiming for a 20% improvement in competitiveness versus its current platform and cost parity with Chinese automakers in Europe. The platform is slated to begin production in Spain in 2027 with the new Peugeot 208 and was showcased at the Mulhouse plant as part of…
Victoria’s Secret shares surged 34% in premarket trading after the company reported broad-based double-digit quarterly revenue growth and raised fiscal 2026 sales and adjusted operating income forecasts. Management attributed the results to stronger selling prices, reduced promotional activity and expanding customer engagement, while noting an unce…
Forbright Inc., a financial-services platform combining middle-market lending with a recently launched digital deposit product, has filed to sell up to 7.9 million shares in an initial public offering priced between $18 and $20 each, seeking proceeds of as much as $158 million. The company reports significant growth in consolidated assets and net i…
Impulse Space announced a $500 million Series D round that sets the company's post-money valuation at $4.26 billion. The financing, co-led by 137 Ventures and Banner VC with participation from existing backers, will be directed to expanding the startup's workforce and manufacturing capacity as it advances missions with its Mira vehicle and prepares…
Virgin Galactic's stock fell sharply after the company announced it would use common stock to redeem a portion of its outstanding First Lien Notes. The plan, disclosed in a securities filing, calls for issuing shares in lieu of cash to retire up to $30.5 million of the 9.80% notes due December 31, 2028, a move the company says is part of its capita…
Impulse Space announced a $500 million Series D round co-led by 137 Ventures and BANNER VC, pushing the company’s total capital raised above $1 billion. The proceeds will be used to expand headcount, broaden manufacturing capacity and scale production of spacecraft and propulsion systems that reposition payloads after launch.
BofA Securities downgraded Nubank from "neutral" to "underperform" and trimmed its price objective to $10 from $16 following the announced departure of CFO Guilherme Lago. The move reflects mounting concern about recent C-suite exits, rising execution risks, and reduced earnings visibility as BofA also lowered its valuation multiple and updated med…
Celcuity Inc. (NASDAQ: CELC) saw its shares decline 15% on Tuesday after the company released detailed efficacy and safety data from the PIK3CA mutant cohort of the Phase 3 VIKTORIA-1 trial. Gedatolisib, tested as both a triplet with fulvestrant and palbociclib and as a doublet with fulvestrant, produced sizable reductions in the risk of disease pr…
Micron Technology’s rapid ascent to a $1 trillion market valuation reflects a sharp strategic pivot catalyzed by Nvidia. Long known for running factories on tight budgets and treating memory as a commodity, Micron revisited its technology and spending approach after Nvidia’s leadership warned that memory would become a bottleneck for AI. That shift…
Shake Shack Inc. shares dropped 7% after the company lowered its guidance for second-quarter revenue, same-shack sales, restaurant-level profit margins and full-year adjusted EBITDA and net income for fiscal 2026. Management cited macroeconomic uncertainty and increased competition while maintaining its licensing revenue target and planned restaura…
